Cargando…
Sickle Cell Anemia Presenting with Vaso-Occlusive Pain: Should We Screen for COVID-19?
Despite the widespread of coronavirus disease-19 (COVID-19) infection around the world, there are very scarce reported literature about the care of patients with a known diagnosis of hemoglobin disorders such as sickle cell disease (SCD) or thalassemia and confirmed COVID-19 infection. Thalassemia...
Autores principales: | Ali, Mohammad, Okar, Lina, Omar, Nabil E., Parengal, Jabeed, Soliman, Ashraf, Yassin, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900454/ http://dx.doi.org/10.1159/000513232 |
Ejemplares similares
-
COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review
por: Okar, Lina, et al.
Publicado: (2020) -
Severe hemolysis and vaso‐occlusive crisis due to COVID‐19 infection in a sickle cell disease patient improved after red blood cell exchange
por: Okar, Lina, et al.
Publicado: (2021) -
S266: DIFFERENT MOLECULAR VASO-OCCLUSIVE TRIGGERS STIMULATE DISTINCT VASO-OCCLUSIVE PROFILES: IN VIVO RESULTS FROM MICE WITH SICKLE CELL ANEMIA
por: Gushiken, Lucas F. S., et al.
Publicado: (2023) -
Immunological Hallmarks of Inflammatory Status in Vaso-Occlusive Crisis of Sickle Cell Anemia Patients
por: Silva-Junior, Alexander Leonardo, et al.
Publicado: (2021) -
Plasma Concentration of Platelet-Derived Microparticles Is Related to Painful Vaso-Occlusive Phenotype Severity in Sickle Cell Anemia
por: Nebor, Danitza, et al.
Publicado: (2014)